AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BUBS AUSTRALIA LTD

0.130

+0.0054.00%

Volume:1.44M

Turnover:192.42K

Market Cap:116.24M

PE:20.94

High:0.135

Open:0.130

Low:0.130

Close:0.125

52wk High:0.190

52wk Low:0.105

Shares:894.13M

Float Shares:684.47M

Volume Ratio:3.13

T/O Rate:0.21%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.006

EPS(LYR):0.006

ROE:13.97%

ROA:4.55%

PB:2.74

PE(LYR):20.94

Loading ...

Overview Company News Filings

Concept

Food Production+1.62%

China Concept Stocks+3.08%

Capital Flow

Inflow:

Outflow:

News

Bubs Australia H1 Revenue AUD 55.5 Million

THOMSON REUTERS

BRIEF-Bubs Australia Says FDA Continues Review Of Bubs' Infant Formula Submissions

Bubs Australia Ltd - FDA Continues Review of Bubs' Infant Formula Submissions

THOMSON REUTERS

Bubs Australia Appears to Have Little Margin for Error -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BUB.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BUB.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BUB.AU\",,,,,undefined,":{"symbol":"BUB.AU","market":"AU","secType":"STK","nameCN":"BUBS AUSTRALIA LTD","latestPrice":0.13,"timestamp":1770613920000,"preClose":0.125,"halted":0,"volume":1440017,"delay":0,"changeRate":0.040000000000000036,"nameEN":"BUBS AUSTRALIA LTD","floatShares":684470300,"shares":894130038,"eps":0.006208,"marketStatus":"Not Yet Opened","change":0.005,"latestTime":"02-09 16:12:00 AEDT","open":0.13,"high":0.135,"low":0.13,"amount":192422,"amplitude":0.04,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.006208,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770678000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.125,"openAndCloseTimeList":[[1770591600000,1770613200000]],"volumeRatio":3.1329304084292233,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BUB.AU\",,,,,undefined,":{"symbol":"BUB.AU","floatShares":684470300,"roa":"4.55%","roe":"13.97%","lyrEps":0.006208,"volumeRatio":3.1329304084292233,"shares":894130038,"dividePrice":0,"high":0.135,"amplitude":0.04,"preClose":0.125,"low":0.13,"week52Low":0.105,"pbRate":"2.74","psRate":"1.13","week52High":0.19,"institutionHeld":0,"latestPrice":0.13,"eps":0.006208,"divideRate":0,"volume":1440017,"delay":0,"ttmEps":0.006208,"open":0.13,"prevYearClose":0.137,"prevWeekClose":0.125,"prevMonthClose":0.135,"prevQuarterClose":0.137,"fiveDayClose":0.13,"twentyDayClose":0.135,"sixtyDayClose":0.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BUB.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-27","symbol":"BUB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740610800000,"name":null,"time":"","dateTimestamp":1740574800000,"actualEps":null},{"date":"2024-02-25","symbol":"BUB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708815600000,"name":null,"time":"","dateTimestamp":1708779600000,"actualEps":null},{"date":"2022-02-23","symbol":"BUB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1645570800000,"name":null,"time":"","dateTimestamp":1645534800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BUB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BUB.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607699520","title":"Bubs Australia H1 Revenue AUD 55.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607699520","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607699520?lang=en_us&edition=fundamental","pubTime":"2026-01-30 10:14","pubTimestamp":1769739244,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nPLXD89D00:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BUB.AU","BK7509","BK7141","BK7505"],"gpt_icon":0},{"id":"2595277199","title":"BRIEF-Bubs Australia Says FDA Continues Review Of Bubs' Infant Formula Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2595277199","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595277199?lang=en_us&edition=fundamental","pubTime":"2025-12-29 09:09","pubTimestamp":1766970587,"startTime":"0","endTime":"0","summary":"BRIEF-Bubs Australia Says FDA Continues Review Of Bubs' Infant Formula SubmissionsDec 29 (Reuters) - Bubs Australia Ltd BUB.AX:FDA CONTINUES REVIEW OF BUBS' INFANT FORMULA SUBMISSIONSCONFIRMS THAT IT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nFWN3XX034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7141","BUB.AU","BK7505","BK7509"],"gpt_icon":0},{"id":"2595927174","title":"Bubs Australia Ltd - FDA Continues Review of Bubs' Infant Formula Submissions","url":"https://stock-news.laohu8.com/highlight/detail?id=2595927174","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595927174?lang=en_us&edition=fundamental","pubTime":"2025-12-29 06:57","pubTimestamp":1766962654,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251228:nFWN3XX034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7141","BUB.AU","BK7509","BK7505"],"gpt_icon":0},{"id":"2590367364","title":"Bubs Australia Appears to Have Little Margin for Error -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2590367364","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590367364?lang=en_us&edition=fundamental","pubTime":"2025-12-09 08:37","pubTimestamp":1765240620,"startTime":"0","endTime":"0","summary":"0037 GMT - Bubs Australia appears to have little margin for error if it is to meet its annual guidance, Bell Potter analyst Jonathan Snape warns. He reckons that the infant-formula maker's guidance for annual revenue of between A$120 million and A$125 million implies a 23% improvement on September-quarter run rates. Writing in a note to clients, Snape observes that the long lead times in formula manufacturing suggest that Bubs needs to build inventory ahead of its anticipated sales uplift. He sees the expected inventory build being funded by existing facilities and cash. Bell Potter cuts its target price 2.9% to A$0.17 and keeps a hold rating on the stock, which is down 1.7% at A$0.1425. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7505","BK7141","BUB.AU","BK7509"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BUB.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Food Production","bkCode":"BK7505","id":"package_au_concept_spg","changeRate":0.016203},{"market":"AU","name":"China Concept Stocks","bkCode":"BK7509","id":"package_au_concept_zgg","changeRate":0.030801}]}}